Fund 13F filing

Marshall Wace added $23.9M of Sarepta Therapeutics, Inc. (SRPT) stock

SEC Form 13F · Filed Aug 13, 2026

Marshall Wace added $23.9M of Sarepta Therapeutics, Inc. (SRPT) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 13, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

Sarepta Therapeutics, Inc.

Value

$23.9M

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.